Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Frontiers in Oncology
|
May 31, 2021
Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant Glioblastoma
Haihui Jiang, Kefu Yu, Yong Cui, et al.
Frontiers in Neurology
|
February 21, 2022
T2/FLAIR Abnormity Could be the Sign of Glioblastoma Dissemination
Mingxiao Li, Wei Huang, Hongyan Chen, et al.
Nature Communications
|
December 16, 2025
A cis-regulatory element of the PHYTOCHROME A gene confers the submergence escape capacity for amphibious plants
Chuanwei Yang, Wenbo Liu, Meiquan Qiu, et al.
Frontiers in Oncology
|
May 7, 2021
Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features
Mingxiao Li, Xiaohui Ren, Gehong Dong, et al.
Journal of Neurosurgery
|
October 15, 2022
Alteration of default mode network: association with executive dysfunction in frontal glioma patients
Xiaokang Zhang, Guobin Zhang, Yonggang Wang, et al.
Frontiers in Neurology
|
January 2, 2023
A prognostic estimation model based on mRNA-sequence data for patients with oligodendroglioma
Qinghui Zhu, Shaoping Shen, Chuanwei Yang, et al.
European Radiology
|
January 26, 2022
Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma
Mingxiao Li, Xiaohui Ren, Xuzhu Chen, et al.
Frontiers in Oncology
|
June 7, 2021
Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features
Mingxiao Li, Xiaohui Ren, Gehong Dong, et al.
Frontiers in Oncology
|
July 5, 2022
Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series
Chuanwei Yang, Yong Cui, Xiaohui Ren, et al.
Cancer Research
|
December 4, 2010
The integrin alpha(v)beta(3-5) ligand MFG-E8 is a p63/p73 target gene in triple-negative breast cancers but exhibits suppressive functions in ER(+) and erbB2(+) breast cancers
Chuanwei Yang, Tetsu Hayashida, Nicole Forster, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Frontiers in Oncology
|
May 31, 2021
Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant Glioblastoma
Haihui Jiang, Kefu Yu, Yong Cui, et al.
Frontiers in Neurology
|
February 21, 2022
T2/FLAIR Abnormity Could be the Sign of Glioblastoma Dissemination
Mingxiao Li, Wei Huang, Hongyan Chen, et al.
Nature Communications
|
December 16, 2025
A cis-regulatory element of the PHYTOCHROME A gene confers the submergence escape capacity for amphibious plants
Chuanwei Yang, Wenbo Liu, Meiquan Qiu, et al.
Frontiers in Oncology
|
May 7, 2021
Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features
Mingxiao Li, Xiaohui Ren, Gehong Dong, et al.
Journal of Neurosurgery
|
October 15, 2022
Alteration of default mode network: association with executive dysfunction in frontal glioma patients
Xiaokang Zhang, Guobin Zhang, Yonggang Wang, et al.
Frontiers in Neurology
|
January 2, 2023
A prognostic estimation model based on mRNA-sequence data for patients with oligodendroglioma
Qinghui Zhu, Shaoping Shen, Chuanwei Yang, et al.
European Radiology
|
January 26, 2022
Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma
Mingxiao Li, Xiaohui Ren, Xuzhu Chen, et al.
Frontiers in Oncology
|
June 7, 2021
Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features
Mingxiao Li, Xiaohui Ren, Gehong Dong, et al.
Frontiers in Oncology
|
July 5, 2022
Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series
Chuanwei Yang, Yong Cui, Xiaohui Ren, et al.
Cancer Research
|
December 4, 2010
The integrin alpha(v)beta(3-5) ligand MFG-E8 is a p63/p73 target gene in triple-negative breast cancers but exhibits suppressive functions in ER(+) and erbB2(+) breast cancers
Chuanwei Yang, Tetsu Hayashida, Nicole Forster, et al.
Page
of 6